Relative risk reduction is a troublesome way to convey the benefits of treatments
How excited would you be about a medication that lowered your risk of cardiovascular death, heart attack or stroke by 1.5%? Excited enough to spend a few thousand dollars a year on the drug? I expect not.
What if, instead, the drug reduced those same terrible outcomes by 20%? That’s probably enough benefit to interest some in the drug.
Well, those statistics come from the same clinical trial, evaluating the same drug. …
Relative risk reduction is a troublesome way to convey the benefits of treatments






![Clinicians are failing at value-based care because no one taught them the system [PODCAST]](https://kevinmd.com/wp-content/uploads/bd31ce43-6fb7-4665-a30e-ee0a6b592f4c-190x100.jpeg)










![Why I would never compromise on withdrawing care until I saw it firsthand [PODCAST]](https://kevinmd.com/wp-content/uploads/Gemini_Generated_Image_6l3h566l3h566l3h-190x100.png)